or Try an Advanced Search...

    Technical Analysis for SER - Serina Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 8.68 -9.39% -0.90
    SER closed down 9.39 percent on Monday, July 1, 2024, on 87 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SER trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Resistance Bearish -9.39%
    Stochastic Buy Signal Bullish -9.39%
    Wide Bands Range Expansion -9.39%
    Oversold Stochastic Weakness -9.39%
    Calm After Storm Range Contraction 1.40%
    NR7 Range Contraction 1.40%
    Older End-of-Day Signals for SER ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 10 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    60 Minute Opening Range Breakdown 3 days ago
    Fell Below Previous Day's Low 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SER Chart by TradingView
    Basic chart:

    Profile

    Serina is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina’s POZ PlatformTM delivery technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (“PEG”) and other biocompatible polymers. Serina’s POZ PlatformTM partners are at the forefront in advancing LNP delivery technology to develop novel RNA therapeutics.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Pain Molecular Biology Polymers RNA Pegylation Neurological Diseases Rna Therapeutics

    Is SER a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Parkinson's-focused Serina Therapeutics, Enable Injections enter partnership
    May 15 Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
    May 14 AgeX Therapeutics GAAP EPS of -$3.38, revenue of $0.05M
    May 14 Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
    May 3 Serina Therapeutics files to sell 1.5M shares of common stock
    Apr 17 Serina Therapeutics appoints Simba Gill as executive chairman
    Apr 17 Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
    Mar 25 AgeX Therapeutics GAAP EPS of -$13.73
    Mar 22 AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
    See more SER news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.5036
    52 Week Low 7.86
    Average Volume 16,746
    200-Day Moving Average 15.18
    50-Day Moving Average 9.52
    20-Day Moving Average 9.75
    10-Day Moving Average 9.66
    Average True Range 1.36
    RSI (14) 45.05
    ADX 26.95
    +DI 23.85
    -DI 18.92
    Chandelier Exit (Long, 3 ATRs) 10.49
    Chandelier Exit (Short, 3 ATRs) 12.11
    Upper Bollinger Bands 11.92
    Lower Bollinger Band 7.57
    Percent B (%b) 0.25
    BandWidth 44.61
    MACD Line -0.23
    MACD Signal Line -0.07
    MACD Histogram -0.1619
    Fundamentals Value
    Market Cap 763.42 Million
    Num Shares 88 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -22.84
    Price-to-Sales 362.10
    Price-to-Book 12.96
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.84
    Resistance 3 (R3) 9.96 9.71 9.64
    Resistance 2 (R2) 9.71 9.41 9.64 9.58
    Resistance 1 (R1) 9.19 9.23 9.07 9.07 9.51
    Pivot Point 8.94 8.94 8.87 8.87 8.94
    Support 1 (S1) 8.42 8.64 8.30 8.30 7.85
    Support 2 (S2) 8.17 8.46 8.10 7.78
    Support 3 (S3) 7.65 8.17 7.72
    Support 4 (S4) 7.53